Currently, the expansion of the novel human respiratory coronavirus (known as SARS-CoV-
2 [severe acute respiratory syndrome coronavirus 2], COVID-2019 [coronavirus disease …

Recent international epidemics of coronavirus-associated illnesses underscore the urgent
medical and public health need for vaccine development and regulatory body approved …

The outbreak of coronavirus disease 2019 (COVID-19) has resulted in a global pandemic
due to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Patients and physicians worldwide are facing tremendous health care hazards that are
caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS …

Abstract The novel coronavirus 2019 (2019-nCoV), formally named severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a novel human infectious coronavirus. The …

The global pandemic of novel coronavirus disease 2019 (COVID‐19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has created an urgent need for …

The coronavirus disease 2019 (COVID-19) pandemic remains uncontrolled despite the
rapid rollout of safe and effective severe acute respiratory syndrome coronavirus 2 (SARS …

The ongoing SARS‐CoV‐2 pandemic stresses the need for effective antiviral drugs that can
quickly be applied in order to reduce morbidity, mortality, and ideally viral transmission. By …

Abstract Remdesivir (GS-5734), a viral RNA-dependent RNA polymerase (RdRP) inhibitor
that can be used to treat a variety of RNA virus infections, is expected to be an effective …

Human coronaviruses (HCoV) were discovered in the 1960s and were originally thought to
cause only mild upper respiratory tract diseases in immunocompetent hosts. This view …